Abiomed Inc (ABMD)
$181.45 1.53 (0.84%)
16:51 EST ABMD Stock Quote Delayed 15 Minutes
Previous Close $182.98
Market Cap 8.07B
PE Ratio 74.06
Volume (Avg. Vol.) 567,222
Day's Range 178.00 - 183.72
52-Week Range 155.02 - 364.31
Dividend & Yield N/A (N/A)
ABMD Stock Predictions, Articles, and Abiomed Inc News
- From InvestorPlace
- From the Web
2019 has been one of the best years for stocks in recent memory. Heading into 2020, here are 10 stocks to buy that are struggling to finish well.
From a list of the 20 best-performing S&P 500 stocks of the past decade, I’ve selected seven that I feel can deliver a repeat performance.
These ten growth stocks saw the highest percentage growth over the last decade, and some remain unknown to investors despite huge increases.
These 7 growth stocks remain positioned for significant future increases, and could bring huge returns to new investors for years to come.
These beaten-down healthcare stocks still have plenty of long-term potential. Here's what investors need to know about each.
The market is climbing a wall of worry. Here are 10 triple-A stocks I recommend to help you profit from the strength.
The markets may be volatile but the trends for these tech stocks are strong.
The tech wreck failed to sink these five companies, making them some of the best stocks to buy in 2018. But can they continue their strength in 2019?
When considering medical devices stocks to buy, consider companies with FDA-approved devices, growing sales and overall financial strength.
These tech stocks prove that there’s plenty of growth out there, if you know where to look. Here's what investors need to know about each.
Medical device stocks could be the best play in all of healthcare. Here are five of the best choices for any portfolio.
Each case for these momentum stocks is backed by Wall Street's top analysts and the stocks should continue to power through 2018 and beyond.
Niche medical device maker Abiomed has plenty of heart for growth. ABMD stock isn't the sexiest play, but it's well worth a look.
From The Motley Fool
From Market News Video
Navellier RatingsPowered by Portfolio Grader